Sustained-Release Transdermal Spray Gel 

Global Innovative Dosage: Directional nebulized dosage form to achieve quantitative drug delivery to the skin.

Unique Sustained-Release Mechanism: The degradable polymer sustained-release skeleton structure is used to form a skin gel film after spraying, to achieve the slow release of active ingredients.

Clinical Advantages: Reducing the number of doses, easy to use, and improve patients' medication compliance.

Children friendly: Compared with conventional topical dermatologic cream or ointment, the gel is not easy to be washed off by water after application, improving pediatric medication compliance.

Innovative Compound Topical Gel

Global Innovative Compound Preparation: New compound with Quinolones antibacterial + Naphthoic acids anti-inflammatory agent.

Special Synergistic Mechanism: Quinolone antibacterials solely will easily induce resistance to Propionibacterium acnes, while naphthoic acid anti-inflammatory agents can effectively inhibit the resistance of Propionibacterium acnes and are expected to have a synergistic effect with quinolone antibacterials to enhance drug efficacy.

Technical barriers breakthrough: Selection of permeability enhancers, gelling agents and emulsifiers, micronization of active ingredients, gel stability, quality research of insoluble ingredients, etc.

Suitable for pediatric population: The active ingredients are listed in relevant domestic and international guidelines for young pediatric patients with high safety.

Patent Layout 

Independent intellectual property rights, covering new dosage form invention patents, with international and domestic layout.